[18F]MNI-815
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]MNI-815, covering 2016-12-16 to 2016-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies [EARLY_Phase 1]